Hdg: ICMR successfully tests first long-lasting male contraceptive

Wednesday, 18 October 2023
The Indian Council of Medical Research (ICMR) has concluded a seven-year study on the male contraceptive RISUG, finding it to be safe and effective. RISUG is a non-hormonal injectable contraceptive that provides long-lasting sterility with complete reversibility. The study involved 303 healthy male volunteers and found that non-hormonal injectable male contraceptive RISUG (Reversible Inhibition of Sperm under Guidance) is safe and efficacious.

👓 View full article

0 shares	Share Tweet Save Post Send

Hdg: ICMR successfully tests first long-lasting male contraceptive

You Might Like

💡 newsR Knowledge: Other News Mentions